Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions

Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications

(2015) Patrick Wuchter et al.   CYTOTHERAPY

Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells

(2014) Ana Valéria Gouveia de Andrade et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Allogeneic cell therapy bioprocess economics and optimization: Single-use cell expansion technologies

(2013) Ana S. Simaria et al.   BIOTECHNOLOGY AND BIOENGINEERING

Fed-batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty

(2012) James Pollock et al.   BIOTECHNOLOGY AND BIOENGINEERING

Assessing commercial opportunities for autologous and allogeneic cell-based products

(2012) Devyn M Smith   Regenerative Medicine

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

(2011) Moïra François et al.   CYTOTHERAPY

Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration

(2011) Aaron R. Cooper et al.   JOURNAL OF VIROLOGICAL METHODS

The Systematic Production of Cells for Cell Therapies

(2008) Daniel C. Kirouac et al.   Cell Stem Cell

Decision-Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation

(2005) Suzanne S. Farid et al.   BIOTECHNOLOGY PROGRESS